Cumulus Neuroscience Confirms Neuroplasticity Measurement Using Innovative EEG Technology#United_Kingdom#EEG_Technology#Belfast#Cumulus_Neuroscience#Neuroplasticity
Cumulus Neuroscience Confirms Neuroplasticity Measurement Using Innovative EEG Technology
Cumulus Neuroscience has published a new study validating a low-burden method for assessing neuroplasticity, revolutionizing clinical trials.
third-news.com
January 6, 2026 at 10:06 AM
Cumulus Neuroscience Confirms Neuroplasticity Measurement Using Innovative EEG Technology#United_Kingdom#EEG_Technology#Belfast#Cumulus_Neuroscience#Neuroplasticity
Upcoming Webinar Focuses on Evolving Neuropsychiatry Clinical Trials with Portable EEG Advances#None#Clinical_Trials#Neuropsychiatry#EEG_Technology
Upcoming Webinar Focuses on Evolving Neuropsychiatry Clinical Trials with Portable EEG Advances
Explore the evolution of neuropsychiatry clinical trials in an enlightening webinar. Gain insights into portable EEG technology and its impact on treatment evaluation.
third-news.com
October 6, 2025 at 1:00 PM
Upcoming Webinar Focuses on Evolving Neuropsychiatry Clinical Trials with Portable EEG Advances#None#Clinical_Trials#Neuropsychiatry#EEG_Technology
Emotiv Unveils Revolutionary MW20 EEG Active Noise-Cancelling Earphones at CES 2025#United_States#San_Francisco#Emotiv#EEG_Technology#MW20_Earphones
Emotiv Unveils Revolutionary MW20 EEG Active Noise-Cancelling Earphones at CES 2025
Discover the cutting-edge MW20 EEG Active Noise-Cancelling Earphones from Emotiv, featuring advanced wellness insights and superior sound quality.
third-news.com
January 6, 2025 at 12:16 PM
Emotiv Unveils Revolutionary MW20 EEG Active Noise-Cancelling Earphones at CES 2025#United_States#San_Francisco#Emotiv#EEG_Technology#MW20_Earphones